The Long COVID Treatment Trial
Summary:
Type:
Status:
Interventions:
Tirzepatide, Placebo
Locations:
La Jolla, United States
Last Updated:
October 31, 2025
Long Covid (LC)-REVITALIZE - A Long Covid Repurposed Drug Study
Summary:
Type:
Status:
Interventions:
Pirfenidone, Placebo for pirfenidone, Upadacitinib, Placebo for upadacitinib
Locations:
San Diego, United States; Rio de Janeiro, Brazil; and 5 more
Last Updated:
October 29, 2025
Heat thErapy And mobiLity in COVID-19 Survivors
Summary:
Type:
Status:
Interventions:
Heat therapy, Sham Control, Walking
Locations:
Omaha, United States
Last Updated:
October 21, 2025
LIFT: Life Improvement Trial
Summary:
Type:
Status:
Interventions:
Pyridostigmine, Low-Dose Naltrexone, Placebo
Locations:
Boston, United States
Last Updated:
October 21, 2025
A Study to Examine Anktiva for the Treatment of COVID-19.
Summary:
Type:
Status:
Interventions:
Anktiva
Locations:
El Segundo, United States
Last Updated:
October 17, 2025
RECOVER-ENERGIZE Platform Protocol
Summary:
Type:
Status:
Interventions:
Personalized Cardiopulmonary Rehabilitation, Structured Pacing, Education, Usual Care
Locations:
Birmingham, United States; Phoenix, United States; and 39 more
Last Updated:
October 2, 2025
Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues
Summary:
Type:
Status:
Interventions:
Liraglutide Pen Injector [Saxenda], Medication Diary
Locations:
Chicago, United States
Last Updated:
September 29, 2025
Study to Investigate the Efficacy of Abrocitinib in Adult Participants With Severe Fatigue From Post COVID Condition/Long COVID
Summary:
Type:
Status:
Interventions:
Abrocitinib, Placebo
Locations:
Boston, United States
Last Updated:
September 26, 2025
NE3107 in Adults With Neurological Symptoms of Long COVID
Summary:
Type:
Status:
Interventions:
NE3107, Placebo
Locations:
San Francisco, United States; Aurora, United States; and 10 more
Last Updated:
September 22, 2025
PET Imaging of Cyclooxygenase-1 in Participants With Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
Summary:
Type:
Status:
Interventions:
11C-PS13
Locations:
Bethesda, United States
Last Updated:
September 19, 2025